Sign in to view content

Effect of Fluocinolone Acetonide 0.2µg/day (ILUVIEN®) Implant on the Decision to Drive in Patients With Differential Control of DME

Seenu M. Hariprasad, MD

Video
Published 2018

Related

Real World Efficacy, Durability and Safety of Faricimab in Neovascular Age-Related Macular Degeneration: The TRUCKEE Study
Carl J Danzig, MD
Updates from the Field
2022
Two-Year Results of an Ongoing Phase 1b/2 Open-Label Clinical Trial of AU-011 for the Primary Treatment of Small to Medium Choroidal Melanoma
Amy C. Schefler, MD FACS FASRS
Annual Meeting Talks
2019
Outcomes of Scleral Tunnel Fixation Techniques
Gareth Lema, MD, PhD
Annual Meeting Talks
2018

Category: Diabetic Retinopathy

See more